On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report 2021. This second annual publication represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates capability and capacity in a broad range of research areas. The report also captures the originating funding location for inward investment in Sponsored clinical trials, again demonstrating Australia’s active participation in the global development process.
In this reporting period Bellberry was also delighted to become the first Australian organisation to achieve accreditation by the global Association for the Accreditation of Human Research Protection Programs (AAHRPP).
If you have any questions relating to this data, please contact us at [email protected]